{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Part+1&page=87", "query": { "intervention": "Part 1", "page": 87 }, "page_size": 10 }, "pagination": { "page": 87, "page_size": 10, "total_count": 6233, "total_pages": 624, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Part+1&page=88&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Part+1&page=86&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-14T11:20:19.162Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03425266", "title": "The Pain App Study: A Novel Shared Decision Making Tool for People With Chronic Pain", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Chronic Pain" ], "interventions": [ { "name": "Interactive decision support tool", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Shared Decision Making Resources", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 80, "start_date": "2018-01-11", "completion_date": "2018-10-31", "has_results": false, "last_update_posted_date": "2023-12-12", "last_synced_at": "2026-11-14T11:20:19.162Z", "location_count": 1, "location_summary": "Georgetown, Maine", "locations": [ { "city": "Georgetown", "state": "Maine" } ], "official_url": "https://clinicaltrials.gov/study/NCT03425266" }, { "nct_id": "NCT05417594", "title": "Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Advanced Solid Malignancies" ], "interventions": [ { "name": "AZD9574", "type": "DRUG" }, { "name": "Temozolomide (TMZ)", "type": "DRUG" }, { "name": "[11C]AZ1419 3391", "type": "DRUG" }, { "name": "Trastuzumab Deruxtecan (T-DXd)", "type": "DRUG" }, { "name": "Datopotamab Deruxtecan (Dato-DXd)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "130 Years", "sex": "ALL", "summary": "18 Years to 130 Years" }, "enrollment_count": 695, "start_date": "2022-06-24", "completion_date": "2028-02-07", "has_results": false, "last_update_posted_date": "2026-10-05", "last_synced_at": "2026-11-14T11:20:19.162Z", "location_count": 11, "location_summary": "La Jolla, California • Los Angeles, California • San Francisco, California + 7 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05417594" }, { "nct_id": "NCT02315066", "title": "Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Neoplasms" ], "interventions": [ { "name": "PF-04518600", "type": "DRUG" }, { "name": "PF-04518600 plus PF-05082566", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 174, "start_date": "2015-04-23", "completion_date": "2020-11-12", "has_results": true, "last_update_posted_date": "2022-04-21", "last_synced_at": "2026-11-14T11:20:19.162Z", "location_count": 24, "location_summary": "Los Angeles, California • Newport Beach, California • Santa Monica, California + 9 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02315066" }, { "nct_id": "NCT00399607", "title": "Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Colorectal Adenomatous Polyps" ], "interventions": [ { "name": "Rectal biopsy during colonoscopy", "type": "PROCEDURE" }, { "name": "Rectal biopsy at randomization", "type": "PROCEDURE" }, { "name": "Rectal biopsy at 1 year", "type": "PROCEDURE" }, { "name": "Rectal biopsy prior to colonoscopy", "type": "PROCEDURE" }, { "name": "Biopsies during colonoscopy", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "45 Years to 75 Years" }, "enrollment_count": 264, "start_date": "2006-06", "completion_date": "2016-08", "has_results": false, "last_update_posted_date": "2016-12-08", "last_synced_at": "2026-11-14T11:20:19.162Z", "location_count": 9, "location_summary": "Los Angeles, California • Denver, Colorado • Atlanta, Georgia + 6 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00399607" }, { "nct_id": "NCT03879798", "title": "DS-3201b and Irinotecan for Patients With Recurrent Small Cell Lung Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Small Cell Lung Cancer" ], "interventions": [ { "name": "DS-3201b", "type": "DRUG" }, { "name": "irinotecan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 22, "start_date": "2019-03-15", "completion_date": "2023-05-02", "has_results": true, "last_update_posted_date": "2024-10-10", "last_synced_at": "2026-11-14T11:20:19.162Z", "location_count": 7, "location_summary": "Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more", "locations": [ { "city": "Basking Ridge", "state": "New Jersey" }, { "city": "Middletown", "state": "New Jersey" }, { "city": "Montvale", "state": "New Jersey" }, { "city": "Commack", "state": "New York" }, { "city": "Harrison", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03879798" }, { "nct_id": "NCT06428500", "title": "QTX3046 in Patients With KRAS G12D Mutations", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Advanced Solid Tumor" ], "interventions": [ { "name": "QTX3046", "type": "DRUG" }, { "name": "Cetuximab", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "DRUG", "COMBINATION_PRODUCT" ], "sponsor": "Quanta Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 240, "start_date": "2024-05-30", "completion_date": "2027-07-01", "has_results": false, "last_update_posted_date": "2025-07-25", "last_synced_at": "2026-11-14T11:20:19.162Z", "location_count": 5, "location_summary": "Grand Rapids, Michigan • Durham, North Carolina • Houston, Texas + 2 more", "locations": [ { "city": "Grand Rapids", "state": "Michigan" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Houston", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT06428500" }, { "nct_id": "NCT00506792", "title": "Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QAU145 in Patients With Cystic Fibrosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cystic Fibrosis" ], "interventions": [ { "name": "QAU145", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 9, "start_date": "2007-07", "completion_date": "2009-11", "has_results": false, "last_update_posted_date": "2020-12-19", "last_synced_at": "2026-11-14T11:20:19.162Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00506792" }, { "nct_id": "NCT04393909", "title": "Improving Safety of Diagnosis and Therapy in the Inpatient Setting", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Delirium", "Confusion", "Mental Status Change", "Back Pain", "Hip Pain Chronic", "Chest Pain", "Asthma", "COPD", "Cellulitis", "Soft Tissue Infections", "Cough", "Deep Vein Thrombosis", "Pulmonary Embolism", "Venous Thromboembolism", "Dyspnea", "Electrolyte Metabolism Abnormal", "Fever", "Failure to Thrive", "Weakness", "Protein-Calorie Malnutrition", "Headache", "Neck Pain", "Hypoxia", "Pneumonia", "Sepsis", "Syncope", "Vomiting", "Diarrhea", "Leg Pain", "Abdominal Pain" ], "interventions": [ { "name": "Diagnostic Uncertainty Educational Curriculum", "type": "BEHAVIORAL" }, { "name": "Diagnostic Timeout", "type": "BEHAVIORAL" }, { "name": "Patient Diagnostic (Dx) Questionnaire", "type": "BEHAVIORAL" }, { "name": "Enhancements to Epic-integrated Quality & Safety Dashboard", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 700, "start_date": "2019-07-01", "completion_date": "2021-12-30", "has_results": false, "last_update_posted_date": "2022-07-26", "last_synced_at": "2026-11-14T11:20:19.162Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04393909" }, { "nct_id": "NCT05716009", "title": "Tagraxofusp-erzs, an IL-3 Diphtheria Fusion Protein, in Combination With Gemtuzumab Ozogamicin in Patients With Relapsed/Refractory AML", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Acute Myeloid Leukemia" ], "interventions": [ { "name": "Dose Escalation -tagraxofusp-erzs", "type": "DRUG" }, { "name": "Dose Expansion at RP2D -tagraxofusp-erzs", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 7, "start_date": "2023-11-20", "completion_date": "2025-07-16", "has_results": false, "last_update_posted_date": "2026-06-25", "last_synced_at": "2026-11-14T11:20:19.162Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT05716009" }, { "nct_id": "NCT03466398", "title": "Effects of a Remote Patient Monitoring Protocol on Glycemic Control in Adolescents With Type 1 Diabetes", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetes Mellitus", "Type 1 Diabetes Mellitus" ], "interventions": [ { "name": "Vivify Health RPM Protocol", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Texas Southwestern Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "13 Years to 18 Years" }, "enrollment_count": 0, "start_date": "2018-04-11", "completion_date": "2020-03-05", "has_results": false, "last_update_posted_date": "2020-05-14", "last_synced_at": "2026-11-14T11:20:19.162Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03466398" } ] }